Latest filings (excl ownership)
S-8
Registration of securities for employees
24 Jul 24
10-Q
2024 Q2
Quarterly report
24 Jul 24
8-K
Alkermes plc Reports Second Quarter 2024 Financial Results
24 Jul 24
8-K
Departure of Directors or Certain Officers
31 May 24
DEFA14A
Additional proxy soliciting materials
14 May 24
10-Q
2024 Q1
Quarterly report
1 May 24
8-K
Alkermes plc Reports First Quarter 2024 Financial Results
1 May 24
ARS
2023 FY
Annual report to shareholders
15 Apr 24
DEFA14A
Additional proxy soliciting materials
15 Apr 24
DEF 14A
Definitive proxy
15 Apr 24
8-K
Regulation FD Disclosure
9 Apr 24
PRE 14A
Preliminary proxy
5 Apr 24
8-K
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
7 Mar 24
10-K
2023 FY
Annual report
21 Feb 24
8-K
Results of Operations and Financial Condition
15 Feb 24
8-K
Departure of Directors or Certain Officers
5 Feb 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
14 Dec 23
8-K
Departure of Directors or Certain Officers
8 Dec 23
8-K
Alkermes Completes Separation of Oncology Business
15 Nov 23
8-K
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement
31 Oct 23
8-K
Other Events
27 Oct 23
10-Q
2023 Q3
Quarterly report
25 Oct 23
8-K
Alkermes plc Reports Third Quarter 2023 Financial Results
25 Oct 23
8-K
Alkermes Presents First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress
23 Oct 23
8-K
Alkermes Announces Settlement With Teva Related to VIVITROL® Patent Litigation
30 Aug 23
S-8
Registration of securities for employees
26 Jul 23
10-Q
2023 Q2
Quarterly report
26 Jul 23
8-K
Alkermes plc Reports Second Quarter 2023 Financial Results
26 Jul 23
8-K
Departure of Directors or Certain Officers
6 Jul 23
8-K
Entry into a Material Definitive Agreement
5 Jul 23
DFAN14A
Additional proxy materials by non-management
28 Jun 23
DFAN14A
Additional proxy materials by non-management
28 Jun 23
DEFA14A
Additional proxy soliciting materials
26 Jun 23
DFAN14A
Additional proxy materials by non-management
26 Jun 23
DEFA14A
Additional proxy soliciting materials
26 Jun 23
DEFA14A
Additional proxy soliciting materials
26 Jun 23
DFAN14A
Additional proxy materials by non-management
22 Jun 23
DEFA14A
Additional proxy soliciting materials
21 Jun 23
DEFA14A
Additional proxy soliciting materials
21 Jun 23
Latest ownership filings
4
David Joseph Gaffin
5 Aug 24
4
Christopher I Wright
1 Jul 24
4
Frank Anders Wilson
1 Jul 24
4
nancy lynn MD snyderman
1 Jul 24
4
BRIAN P MCKEON
1 Jul 24
4
CATO T LAURENCIN
1 Jul 24
4
RICHARD GAYNOR
1 Jul 24
4
David Angelo Jr. Daglio
1 Jul 24
4
Shane Cooke
1 Jul 24
4
Emily Peterson Alva
1 Jul 24
4
Emily Peterson Alva
10 Jun 24
4
Christopher I Wright
10 Jun 24
4
Christopher I Wright
4 Jun 24
4
Frank Anders Wilson
4 Jun 24
4
nancy lynn MD snyderman
4 Jun 24
4
BRIAN P MCKEON
4 Jun 24
4
Nancy Lurker
4 Jun 24
4
CATO T LAURENCIN
4 Jun 24
4
RICHARD GAYNOR
4 Jun 24
4
David Angelo Jr. Daglio
4 Jun 24
4
Shane Cooke
4 Jun 24
4
Emily Peterson Alva
4 Jun 24
4
Nancy Lurker
12 Apr 24
144
Notice of proposed sale of securities
18 Mar 24
4
Christian Todd Nichols
18 Mar 24
3
Nancy Lurker
15 Mar 24
4
Christian Todd Nichols
27 Feb 24
4
Samuel Joseph Parisi
27 Feb 24
4
Iain Michael Brown
27 Feb 24
4
David Joseph Gaffin
27 Feb 24
4
MICHAEL J LANDINE
27 Feb 24
4
Blair Curtis Jackson
27 Feb 24
4
Craig C. Hopkinson
27 Feb 24
4
RICHARD F POPS
27 Feb 24
4
Samuel Joseph Parisi
23 Feb 24
4
Christian Todd Nichols
23 Feb 24
4
MICHAEL J LANDINE
23 Feb 24
4
Blair Curtis Jackson
23 Feb 24
4
Craig C. Hopkinson
23 Feb 24
4
David Joseph Gaffin
23 Feb 24